Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 2, 2016, Pages 252-253

  Benn, Peter ^a   Norwitz, Errol R ^b   Pergament, Eugene ^c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG; CELL FREE NUCLEIC ACID;

ANEUPLOIDY; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; DNA DETERMINATION; DNA SCREENING; DOWN SYNDROME; FETUS; FETUS DISEASE; FIRST TRIMESTER PREGNANCY; HUMAN; LETTER; MONOSOMY X; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SEQUENTIAL SCREENING; SEX CHROMOSOME ABERRATION; TRISOMY 13; TRISOMY 18; CHROMOSOME DISORDER;

CELL-FREE NUCLEIC ACIDS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; HUMANS;

EID: 84969513607     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.04.012     Document Type: Letter

References (4)

1. 1 Norton, M.E., Baer, R.J., Wapner, R.J., Kuppermann, M., Jelliffe-Pawlowski, L.L., Currier, R.J., Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities. Am J Obstet Gynecol 214 (2016), 727.e1–727.e6.
2. 2 Baer, R.J., Flessel, M.C., Jelliffe-Pawlowski, L.L., et al. Detection rates for aneuploidy by first-trimester and sequential screening. Obstet Gynecol 126 (2015), 753–759.
3. 3 Benn, P.A., Prenatal diagnosis of chromosome abnormalities through chorionic villus sampling and amniocentesis. Milunsky, A., Milunsky, J.M., (eds.) Genetic disorders and the fetus: diagnosis, prevention and treatment, 7th ed, 2016, Wiley Blackwell, Chichester, England, 178–266.
4. 4 Craig, W.Y., Haddow, J.E., Palomaki, G.E., Roberson, M., Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS). Prenat Diagn 27 (2007), 409–414.